Back to top
Close
Steve Reitmeister

"Today, I Will Give You
5 Stocks to Double Absolutely Free"

Dear Zacks.com Visitor,

I invite you to download a free Special Report that names 5 tickers, each tabbed by a Zacks expert to gain +100% and more in the next 12 months.

The Next Great Innovator looks to change not an industry but an entire economy with earnings expected to skyrocket more than 2,000% in 2015. A recent IPO already has a fortress in its segment. Don't miss these stocks with compelling gain potential.

Tetraphase Phar: (TTPH)

(Market Close from NSDQ) As of Nov 24, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$24.49 USD

24.49
2,529,121

+2.40 (10.87%)

Volume: 2,529,121

Zacks Rank : 2-Buy [?]   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

After-Market: $24.49 0.00 (0.00%) 4:59 PM ET

Quote Overview

Stock Activity

Open 25.00
Day Low 23.72
Day High 25.40
52 Wk Low 8.01
52 Wk High 26.34
Avg. Volume 402,302
Market Cap 677.24 M
Dividend 0.00 ( 0.00%)
Beta 0.38

Key Earnings Data

Forward PE NA
PEG Ratio NA
Current Qtr Est -0.60
Current Yr Est -2.37
Most Accurate Est -0.60
Qtr Earnings ESP[?] 0.00%
Exp Earnings Date 3/5/15
Prior Year EPS -2.28
Exp EPS Growth NA
Industry MED-DRUGS

Earnings ESP (Expected Surprise Prediction) is Zacks’ proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement.

Read more about this innovative method in the Zacks Earnings ESP Guide See all the top Earnings ESP Stocks.

Premium Research for TTPH

Zacks Rank [?] Buy 2
Zacks Industry Rank 84 / 265 (Top 32%)
Equity Research Report

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn more about the Zacks Rank

Zacks Rank Home - All Zacks Rank resources in one place

Zacks Premium - The only way to get access to the Zacks Rank

( = Change in last 30 days)

View All Zacks Rank #1 Strong Buys

Learn to Profit from the Zacks Rank

Zacks Recommendation has been removed. Learn more

Due to overwhelming customer feedback we have removed the Zacks Recommendation. Unfortunately, having two separate rating systems proved far too confusing to most investors. Going forward we will just focus on the Zacks Rank which has a longer and more impressive track record of outperformance. Even though the Zacks Rank is primarily used for stock trading in a 1-3 month time frame, it also can be very helpful for long term investors. To learn more about using the Zacks Rank for long term investing, click here.

Premium Research : Industry Analysis

Top Peers Symbol Zacks Rank
TETRAPHASE PHAR TTPH
CYNAPSUS THERAP CYNAF
LANNETT INC LCI
PORTOLA PHARMA PTLA
SAGENT PHARMA SGNT
SUCAMPO PHARMAC SCMP
VALEANT PHARMA VRX
ACELRX PHARMACT ACRX
ALEXZA PHARMACT ALXA
ARQULE INC ARQL

See all MED-DRUGS Peers>>